Evidence map›Paper›PMID 37504840›Full record

ArticleJournal of functional biomaterials2023

Efficacy of Pegylated Hyaluronic Acid Filler Enriched with Calcium Hydroxyapatite: A 24-Week Post-Market, Observational, Prospective, Open-Label, Single-Center Study.

Nicola Zerbinati, Edoardo D'Este, Annalisa De Silvestri, Marco Zullino, Giulio Rabbiosi, Stefania Guida, Paweł Kubik, Giorgio Stabile, Roberto Mocchi, Chiara Barlusconi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of functional biomaterials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Nicola ZerbinatiDermatologic Unit, Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy.
Edoardo D'EsteDermatologic Unit, Centro Medico Polispecialistico, 27100 Pavia, Italy.
Annalisa De SilvestriUnit of Clinic Epidemiology and Biometric Scientific Direction, Foundation IRCCS Policlinic San Matteo, 27100 Pavia, Italy.ORCID 0000-0003-3128-8441
Marco ZullinoDepartment of Mathematics and Applications, University of Milan Bicocca, 20125 Milano, Italy.
Giulio RabbiosiDermatologic Unit, Centro Medico Polispecialistico, 27100 Pavia, Italy.
Stefania GuidaMeidicine and Surgery Department, Università Vita-Salute San Raffaele, 20132 Milan, Italy.
Paweł KubikCentrum Medyczne dr Kubik, Skwer Kościuszki 15/17, 81-370 Gdynia, Poland.
Giorgio StabileMeidicine and Surgery Department, Università Vita-Salute San Raffaele, 20132 Milan, Italy.
Roberto MocchiUB-CARE S.r.l.-Spin-Off, University of Pavia, 27100 Pavia, Italy.
Chiara BarlusconiDepartment of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari, 70121 Bari, Italy.
Sabrina SommatisCentrum Medyczne dr Kubik, Skwer Kościuszki 15/17, 81-370 Gdynia, Poland.
Giovanna CipollaDermatologic Unit, Centro Medico Polispecialistico, 27100 Pavia, Italy.
Vita-Salute San Raffaele University · ITPoliclinico San Matteo Fondazione · ITUniversity of Bari Aldo Moro · ITUniversity of Insubria · ITUniversity of Milano-Bicocca · ITUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, thanks to the greater discovery of the mechanisms of facial aging, an alternative to invasive plastic surgery has found space with less invasive aesthetic procedures, also based on an increasingly pressing request. We are specifically referring to dermal filler injection into or under the skin which leads to immediate rejuvenation and aesthetic improvements. In this study, we wanted to analyze the results obtained through the use of NEAUVIA Organic Stimulate, particularly with regard to its effectiveness, which is a cross-linked polymeric hydrogel, containing stabilized sodium hyaluronate 26 mg/mL and calcium hydroxyapatite (1%), glycine and L-proline in buffer pyrogen-free water, in its main indication, namely, the temporary correction of congenital and acquired deficiencies of the soft tissues of the face by intradermal injection. Initially, 70 patients were enrolled, but 10 did not complete the study due to non-observance of the investigation rules, so they were excluded from the protocol. The collected data demonstrate an efficient mechanical effect of the pegylated polymeric acid matrix enriched with low concertation of calcium hydroxyapatite and in accordance with other evidence in vitro and in vivo, and the mechanical support of the interstitial connective space improves the homestays of the anatomical layer rebalancing the physiological activity of the dermis cells.

Indexed as

calcium hydroxyapatitefacial agingpegylated hyaluronic acid filler

Identifiers

PMID37504840
PMCPMC10381780
OpenAlexW4382777419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.